S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

AIPOCH Launches Open-Science Workbench to Standardize AI Research

AIPOCH has released Open-Science, an open-source workbench designed to unify fragmented AI research workflows. By introducing .science packages, the platform allows researchers to bundle conversation histories, code, and data into a single portable format, aiming to improve transparency and reproducibility in the era of agentic AI.

AIPOCH Launches Open-Science Workbench to Standardize AI Research
Photo: Bio & News

The workbench functions as a research operating system, integrating AI agents with local and remote computing resources to eliminate the need for switching between disconnected tools. With 525 marketplace skills and support for four agent frameworks—including Claude Code and OpenCode—it addresses common industry pain points like vendor lock-in and opaque AI outputs. By utilizing standards such as RO-Crate, the system ensures that research context remains inspectable and shareable across different institutions.

Development of the platform involved a global coalition of 76 institutions, including Amsterdam UMC, Beth Israel Deaconess Medical Center, and various leading universities. The Apache 2.0-licensed software enables researchers to execute Python, R, and shell workflows directly, creating immutable, traceable artifacts. According to AIPOCH CEO Huimei Wang, the goal is to shift research toward an open ecosystem where scientific methods and AI capabilities are reused to accelerate discovery.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!